Evolving Therapies in Metastatic Prostate Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 15 June 2025 | Viewed by 1094
Special Issue Editors
Interests: urologic cancers; prostate cancer; laparoscopic; surgeries
Special Issue Information
Dear Colleagues,
Welcome to this Special Issue of "Evolving Therapies in Metastatic Prostate Cancer". Prostate cancer remains the most commonly diagnosed malignancy in men in the United States and worldwide. With the advancements in localized therapy, men are enjoying extended survival with prostate cancer; however, many men will develop recurrence and progression to metastatic disease. The advancements in medical therapies available for metastatic disease over the last 15 years have nearly doubled the time men can survive with metastatic disease. Challenges with the appropriate sequencing of the multitude of new medications available for metastatic prostate cancer are now faced by clinicians. We hope that you gain additional knowledge regarding the prostate cancer treatment landscape currently available for patients with metastatic prostate cancer.
Dr. Joseph Renzulli
Dr. Soum D. Lokeshwar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- metastatic prostate cancer
- metastatic disease
- therapies
- men’s health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
